Lucid Diagnostics (LUCD) Interest Coverage Ratio Growth (3y) (2023 - 2026)
Lucid Diagnostics (LUCD) Interest Coverage Ratio Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 43.57% |
| 10 | Lucid Diagnostics | 176.26 Mn | 142.85 Mn | 55,000.00 | -294.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.09% |
| Mar 31, 2026 | 47.95% |
| Dec 31, 2025 | -376.50% |
| Sep 30, 2025 | -18.23% |
| Jun 30, 2025 | 53.66% |
| Mar 31, 2025 | 51.43% |
| Dec 31, 2024 | 34.87% |
| Sep 30, 2024 | -30.29% |
| Jun 30, 2024 | 12.34% |
| Dec 31, 2023 | 247.72% |